S.Biomedics Co., Ltd.
304360 | KO
Overview
Corporate Details
- ISIN(s):
- KR7304360001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 성수이로26길 28 (성수동2가, 우일벤처타운) 4층, 성동구
- Website:
- https://www.sbiomedics.com/eng/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-07-11 00:00 |
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 107.2 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.1 KB | ||
| 2025-06-16 00:00 |
Share Issue/Capital Change
전환가액의조정 (제6회차)
|
Korean | 10.9 KB | ||
| 2025-06-16 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
전환가액의조정 (제5회차)
|
Korean | 10.9 KB | ||
| 2025-06-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 107.6 KB | ||
| 2025-05-14 00:00 |
Regulatory Filings
신규시설투자등
|
Korean | 7.5 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 113.8 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 28.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.3 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.3 KB | ||
| 2025-03-25 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 160.7 KB |
Automate Your Workflow. Get a real-time feed of all S.Biomedics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for S.Biomedics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for S.Biomedics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.
United States of America
ADPT
United States of America
ADPT
Invents and licenses foundational IP for the media and semiconductor industries.
United States of America
ADEA
United States of America
ADEA
Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.
United States of America
ADTX
United States of America
ADTX
Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.
United States of America
ADVB
United States of America
ADVB
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
United States of America
AIM
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America
AIMD
United States of America
AIMD
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
United States of America
AKRO
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany
NMI
Germany
NMI
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
United States of America
TCRT
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
United States of America
ALGS